Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

Core Viewpoint - Establishment Labs Holdings Inc. reported a quarterly loss of $0.62 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.52, indicating a negative earnings surprise of -19.23% [1] Financial Performance - The company posted revenues of $44.12 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 1.85%, but down from $48.56 million in the same quarter last year [2] - Over the last four quarters, Establishment Labs has exceeded consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Establishment Labs shares have increased approximately 32.9% since the beginning of the year, significantly outperforming the S&P 500's gain of 8.7% [3] Future Outlook - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is -$0.41 on revenues of $46.42 million, and for the current fiscal year, it is -$1.80 on revenues of $179.45 million [7] Industry Context - The Medical Services industry, to which Establishment Labs belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, which may impact the stock's performance [8]